Canakinumab Subcutaneous and Dorzolamide and timolol ophthalmic
Determining the interaction of Canakinumab Subcutaneous and Dorzolamide and timolol ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: dorzolamide / timolol ophthalmic
Brand name: Cosopt, Cosopt PF
Synonyms: Dorzolamide and Timolol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Dorzolamide and Timolol Ophthalmic Solution
- Canakinumab Subcutaneous-Dorzolamide and Timolol Preservative-Free Eye Drops
- Canakinumab Subcutaneous-Dorzolamide Hydrochloride
- Canakinumab Subcutaneous-Dorzolamide ophthalmic
- Canakinumab Subcutaneous-Dostinex
- Canakinumab Subcutaneous-Dotarem
- Dorzolamide and timolol ophthalmic-Canasa
- Dorzolamide and timolol ophthalmic-Canasa Pac rectal
- Dorzolamide and timolol ophthalmic-Canasa rectal
- Dorzolamide and timolol ophthalmic-Cancidas
- Dorzolamide and timolol ophthalmic-Candesartan
- Dorzolamide and timolol ophthalmic-Candesartan and Hydrochlorothiazide